Patents by Inventor Tommy TILLMAN

Tommy TILLMAN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Engineered receptors and their use
    Patent number: 9624288
    Abstract: Engineered chloride channel receptors, nucleic acids encoding these receptors, expression vectors including these nucleic acids are disclosed herein. Nanoparticles and pharmaceutical compositions including these engineered chloride channel receptors, nucleic acids, and expression vectors are disclosed. The use of these compositions and nanoparticles, such as for the treatment of pain, cystic fibrosis and asthma, is also disclosed.
    Type: Grant
    Filed: December 9, 2013
    Date of Patent: April 18, 2017
    Assignee: University of Pittsburgh—Of the Commonwealth System of Higher Education
    Inventors: Yan Xu, Pei Tang, Tommy Tillman
  • ENGINEERED RECEPTORS AND THEIR USE
    Publication number: 20150307582
    Abstract: Engineered chloride channel receptors, nucleic acids encoding these receptors, expression vectors including these nucleic acids are disclosed herein. Nanoparticles and pharmaceutical compositions including these engineered chloride channel receptors, nucleic acids, and expression vectors are disclosed. The use of these compositions and nanoparticles, such as for the treatment of pain, cystic fibrosis and asthma, is also disclosed.
    Type: Application
    Filed: December 9, 2013
    Publication date: October 29, 2015
    Applicant: University of Pittsburgh-Of the Commonwealth System of Higher Education
    Inventors: Yan XU, Pei TANG, Tommy TILLMAN